US 11712474
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
granted A61KA61K31/05A61K31/658
Quick answer
US patent 11712474 (Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition) held by Regen Biopharma, Inc. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regen Biopharma, Inc.
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/05, A61K31/658, A61K31/7088, A61K31/7105